brentuximab vedotin
Selected indexed studies
- Brentuximab vedotin in T-cell lymphoma. (Expert Rev Hematol, 2019) [PMID:30526166]
- Brentuximab vedotin. (MAbs, 2012) [PMID:22684302]
- Brentuximab vedotin. (Clin Cancer Res, 2013) [PMID:23155186]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Brentuximab vedotin in T-cell lymphoma. (2019) pubmed
- Brentuximab vedotin. (2012) pubmed
- Brentuximab vedotin. (2013) pubmed
- Brentuximab vedotin use in pediatric anaplastic large cell lymphoma. (2023) pubmed
- Brentuximab vedotin. (2011) pubmed
- Brentuximab vedotin in combination with chemotherapy for pediatric patients with ALK+ ALCL: results of COG trial ANHL12P1. (2021) pubmed
- Brentuximab Vedotin-Driven Microtubule Disruption Results in Endoplasmic Reticulum Stress Leading to Immunogenic Cell Death and Antitumor Immunity. (2024) pubmed
- Brentuximab vedotin and its use in the treatment of advanced Hodgkin's lymphoma. (2020) pubmed
- Brentuximab vedotin. (2014) pubmed
- Brentuximab Vedotin: A Review in CD30-Positive Hodgkin Lymphoma. (2017) pubmed